首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   4509篇
  免费   222篇
  国内免费   21篇
耳鼻咽喉   27篇
儿科学   119篇
妇产科学   178篇
基础医学   616篇
口腔科学   101篇
临床医学   482篇
内科学   1040篇
皮肤病学   40篇
神经病学   334篇
特种医学   165篇
外科学   770篇
综合类   28篇
预防医学   175篇
眼科学   142篇
药学   244篇
中国医学   1篇
肿瘤学   290篇
  2023年   20篇
  2022年   31篇
  2021年   77篇
  2020年   48篇
  2019年   55篇
  2018年   89篇
  2017年   64篇
  2016年   99篇
  2015年   102篇
  2014年   171篇
  2013年   152篇
  2012年   209篇
  2011年   219篇
  2010年   164篇
  2009年   153篇
  2008年   266篇
  2007年   279篇
  2006年   260篇
  2005年   273篇
  2004年   210篇
  2003年   231篇
  2002年   230篇
  2001年   116篇
  2000年   90篇
  1999年   83篇
  1998年   60篇
  1997年   64篇
  1996年   58篇
  1995年   40篇
  1994年   37篇
  1993年   30篇
  1992年   51篇
  1991年   38篇
  1990年   53篇
  1989年   39篇
  1988年   33篇
  1987年   34篇
  1986年   38篇
  1985年   30篇
  1984年   31篇
  1983年   31篇
  1982年   24篇
  1981年   21篇
  1979年   28篇
  1978年   27篇
  1977年   25篇
  1974年   19篇
  1973年   21篇
  1972年   22篇
  1971年   20篇
排序方式: 共有4752条查询结果,搜索用时 31 毫秒
101.
Journal of Interventional Cardiac Electrophysiology - The study sought to assess the prognostic impact of chronic kidney disease (CKD) in patients with electrical storm (ES). ES represents a...  相似文献   
102.
In den letzten Jahren wurden zahlreiche Prognoseparameter zur Beurteilung der cerebralen Hypoxie nach kardiopulmonaler Reanimation untersucht. Diese Parameter umfassen neben klinischen Daten und klinischen Scoresystemen, verschiedene klinisch-neurologische Befunde, biochemische Parameter, elektrophysiologische Untersuchungen und neurodiagnostische bildgebende Verfahren.    Ziel der ?sterreichischen interdisziplin?ren Konsensuskonferenz war die kritische Evaluierung dieser Parameter und die Empfehlung welche Parameter bzw. diagnostischen Ma?nahmen zu welchem Zeitpunkt eine prognostische Aussage über eine potentielle neurologische Rehabilitation nach cerebraler Hypoxie erm?glichen. Aus mehr als 100 unterschiedlichen Parametern wurden 26 Parameter identifiziert, die, basierend auf Ergebnisse wissenschaftlicher Publikationen, eine prognostische Aussage erm?glichen. Diese Parameter müssen jedoch hinsichtlich der Einsch?tzung der Evidenz und deren St?rkegrad als Grundlage für prognostische Empfehlungen unterschiedlich beurteilt werden.  相似文献   
103.
104.
Pruritus due to cholestatic liver disease can be particularly difficult to manage and frequently is intractable to a variety of medical therapies. The aim of our study is to evaluate the efficacy of delta-9-tetrahydrocannabinol (delta-9-THC) for intractable cholestatic related pruritus (ICRP) that has failed conventional (and unconventional) remedies. Three patients were evaluated for plasmapheresis because of ICRP. All 3 patients had previously been extensively treated with standard therapies for ICRP including: diphenhydramine, chlorpheniramine, cholestyramine, rifampicin, phenobarbital, doxepin, naltrexone, UV therapy, and topical lotions. Even multiple courses of plasmapheresis were performed without any benefit for the intractable pruritus. All patients reported significant decreases in their quality of life, including lack of sleep, depression, inability to work, and suicidal ideations. All patients were started on 5 mg of delta-9-THC (Marinol) at bedtime. All 3 patients reported a decrease in pruritus, marked improvement in sleep, and eventually were able to return to work. Resolution of depression occurred in two of three. Side effects related to the drug include one patient experiencing a disturbance in coordination. Marinol dosage was decreased to 2.5 mg in this patient with resolution of symptoms. The duration of antipruritic effect is approximately 4-6 hrs in all three patients suggesting the need for more frequent dosing. Delta-9-tetrahydrocannabinol may be an effective alternative in patients with intractable cholestatic pruritus.  相似文献   
105.
106.
Advances in myocardial perfusion imaging have firmly established the use of noninvasive techniques capable of providing useful information over a broad range of diagnostic and therapeutic cardiovascular problems. Evaluating regional myocardial perfusion abnormalities is a cornerstone for the diagnosis of coronary artery disease, risk assessment in those with known disease, and determination of myocardial viability. The clinical use of myocardial perfusion imaging and the current limitations of existing techniques continue to promote the development of new technologies capable of assessing microvascular and capillary perfusion abnormalities on a global myocardial level. Myocardial contrast echocardiography is an emerging technique capable of rapidly assessing myocardial perfusion at the capillary level in many different clinical settings. This article focuses on myocardial contrast-enhanced ultrasound perfusion techniques, emphasizing the unique information this modality provides compared with other noninvasive perfusion imaging techniques.  相似文献   
107.
OBJECTIVE: To investigate the prevalence of subclinical atherosclerosis among patients with psoriatic arthritis (PsA). METHODS: Forty patients with PsA were enrolled. Controls were matched by age, sex, and atherosclerotic risk factors. All patients and controls underwent duplex scan of the carotid arteries. Carotid intima-media thickness (IMT) was evaluated and the presence of atherosclerotic plaques was recorded. The plaques were graded and carotid plaque index was calculated. RESULTS: Patients with PsA had a higher IMT (mean +/- standard deviation, 1.04 +/- 0.35 mm vs 0.88 +/- 0.29 mm in controls; p = 0.03), and had a higher carotid plaque index than did matched controls (2.3 +/- 2.6, compared to 1.12 +/- 2.09; p = 0.03). Multivariate analysis demonstrated that PsA status as well as age and triglyceride levels were associated with the presence of carotid plaque. Other traditional risk factors were more prevalent among patients with PsA; however, they were not statistically significant. CONCLUSION: Our study demonstrates that patients with PsA may have an increased prevalence of subclinical atherosclerosis. These findings may not be solely attributable to traditional risk factors alone. Special attention and strict control of atherosclerotic risk factors in patients with PsA is warranted.  相似文献   
108.
109.
Neopterin is known in humans as a sensitive marker for diseases associated with increased activity of the cellular immune system. Recent studies report neopterin also to exhibit distinct effects: neopterin induces inducible nitric oxide synthase expression in rat vascular smooth muscle cells and activates translocation of nuclear factor- kappa B. Neopterin may also induce oxidative stress causing apoptotic cell death, or superinduce tumor necrosis factor- alpha -mediated apoptosis. Observing these effects in cell cultures, we were interested in possible consequences of neopterin on cardiac function in the isolated perfused rat heart. The influence of neopterin in three different concentrations (10 micromol/l, 50 micromol/l, 100 micromol/l) on cardiac contractility parameters and coronary vascular resistance were studied in 67 male Sprague-Dawley rats using the temperature-controlled and pressure-constant Langendorff apparatus with retrograde perfusion of the aorta with a Krebs-Henseleit buffer. Treatment with 100 micromol/l neopterin resulted in a significant decrease in coronary flow and cardiac contractility. Coronary flow decreased from 15.2 to 9.5 ml/min (P=0.002), left ventricular pressure from 80 to 52 mmHg (P=0. 002), rate of pressure fall from 1605 to 923 mmHg/s (P=0.001) and rate of pressure rise from 2862 to 1709 mmHg/s (P=0.001). Concentrations lower than 100 micromol/l neopterin had no significant effect on cardiac function. Our study demonstrates a considerable influence of exogenous neopterin on cardiac performance in the Langendorff model of isolated perfused rat hearts. This has to be considered a potential pathogenic factor of cardiac disturbances in diseases in which high concentrations of neopterin are released due to immune activation. At present the exact mechanism remains unclear.  相似文献   
110.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号